Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ALKYLIDENE DERIVATIVES AS KRAS INHIBITORS
Document Type and Number:
WIPO Patent Application WO/2023/284730
Kind Code:
A1
Abstract:
The present disclosure provides certain alkylidenyl derivatives that inhibit certain K-Ras proteins and are therefore useful for the treatment of cancers mediated by such proteins. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds. 114342739v.1

Inventors:
FU JIPING (US)
LOU YAN (US)
SUN YONGFENG (CN)
Application Number:
PCT/CN2022/105169
Publication Date:
January 19, 2023
Filing Date:
July 12, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
NIKANG THERAPEUTICS INC (US)
SHANGHAI BLUERAY BIOPHARMA CO LTD (CN)
International Classes:
C07D519/00; A61K31/519; A61P35/00
Domestic Patent References:
WO2021041671A12021-03-04
WO2020146613A12020-07-16
WO2021106231A12021-06-03
WO2019099524A12019-05-23
WO2016049565A12016-03-31
WO2016164675A12016-10-13
WO2016168540A12016-10-20
WO2017015562A12017-01-26
WO2017058728A12017-04-06
WO2017058768A12017-04-06
WO2017058792A12017-04-06
WO2017058805A12017-04-06
WO2017058807A12017-04-06
WO2017058902A12017-04-06
WO2017058915A12017-04-06
WO2017070256A22017-04-27
WO2017087528A12017-05-26
WO2017100546A12017-06-15
WO2017172979A12017-10-05
WO2017201161A12017-11-23
WO2018064510A12018-04-05
WO2018068017A12018-04-12
WO2018119183A22018-06-28
WO2009036082A22009-03-19
WO2009055730A12009-04-30
WO2006122806A22006-11-23
WO2001002369A22001-01-11
WO2002066470A12002-08-29
WO2002010192A22002-02-07
WO2005028443A22005-03-31
WO2006028958A22006-03-16
WO2009155386A12009-12-23
WO2003064383A22003-08-07
WO2003075836A22003-09-18
Foreign References:
US6780996B22004-08-24
US4169846A1979-10-02
US4261989A1981-04-14
US5621002A1997-04-15
US5266573A1993-11-30
Other References:
SCIENCE, vol. 294, 2001, pages 1299 - 304
CURR BIOL, vol. 15, 2005, pages 563 - 74
CURR. BIOL., vol. 15, 2005, pages 563 - 74
LUNG CANCER, vol. 124, 2018, pages 53 - 64
MOL. CELL BIOL., vol. 15, 1995, pages 6443 - 6453
CELL, vol. 129, 2007, pages 957 - 968
PROC. NATL. ACAD. SCI. U. S. A., vol. 91, 1994, pages 11089 - 11093
CANCER DISCOV., vol. 11, 2021, pages 1 - 16
ACS CENT. SCI., vol. 6, 2020, pages 1753 - 1761
CELL, vol. 183, no. 4, 2020, pages 850 - 859
T.W. GREENE: "Protective Groups in Organic Synthesis", 2014, JOHN WILEY & SONS, INC.
TESTA, BERNARDMAYER, JOACHIM M.: "Hydrolysis in Drug and Prodrug Metabolism: Chemistry, Biochemistry, and Enzymology", 2003, WILEY-VHCA
"Pharmaceutical Sciences", 2000, MACK PUBLISHING COMPANY
"Reagents for Organic Synthesis", vol. 1-40, 1991, JOHN WILEY AND SONS
"s Comprehensive Organic Transformations", vol. 1-5, 1989, ELSEVIER SCIENCE PUBLISHERS
CAS , no. 1070790-89-4
CAS , no. 1029872- 29-4
CAS, no. 1816989-16-8
SYNLETT, 1999, pages 1660 - 1662
J. ORG. CHEM., vol. 61, 1996, pages 6936 - 6940
Attorney, Agent or Firm:
CHINA PATENT AGENT (H.K.) LTD. (CN)
Download PDF: